financetom
Business
financetom
/
Business
/
Ormat Technologies Begins Commercial Operations of Montague Energy Storage Facility
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ormat Technologies Begins Commercial Operations of Montague Energy Storage Facility
Dec 30, 2024 7:18 AM

10:01 AM EST, 12/30/2024 (MT Newswires) -- Ormat Technologies ( ORA ) said Monday its Montague energy storage facility has started commercial operations.

The 20 megawatt/20 megawatt hour battery energy storage system in New Jersey will provide ancillary services on the merchant market to Pennsylvania, New Jersey and Maryland, Ormat ( ORA ) said.

The project is expected to be eligible for a 30% investment tax credit, the company said.

Price: 67.33, Change: -0.58, Percent Change: -0.85

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dua Lipa beats lawsuit claiming she copied 'Levitating'
Dua Lipa beats lawsuit claiming she copied 'Levitating'
Mar 27, 2025
NEW YORK, March 27 (Reuters) - Dua Lipa won the dismissal on Thursday of a lawsuit in Manhattan accusing the British pop star of copying her 2021 megahit Levitating from a 1979 disco song. U.S. District Judge Katherine Polk Failla said L. Russell Brown and Sandy Linzer failed to show substantial similarity between Levitating and their song Wiggle and Giggle...
Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug
Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug
Mar 27, 2025
The Japanese Ministry of Health, Labour and Welfare on Thursday approved BridgeBio Pharma, Inc. ( BBIO )‘s acoramidis, under the brand name Beyonttra, for adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM). Acoramidis is a selective small molecule, orally administered, near-complete (≥90%) transthyretin (TTR) stabilizer. ATTR-CM is a progressive, fatal disease that presents as an infiltrative, restrictive cardiomyopathy, resulting in heart failure. AstraZeneca Plc...
Alcoa's Q1 Adjusted Earnings Seen Topping Estimates, UBS Says
Alcoa's Q1 Adjusted Earnings Seen Topping Estimates, UBS Says
Mar 27, 2025
03:16 PM EDT, 03/27/2025 (MT Newswires) -- Alcoa's ( AA ) Q1 adjusted earnings probably will top Wall Street estimates amid a constructive outlook for aluminum, UBS AG London said Thursday in a report. UBS forecasts Q1 adjusted earnings of $1.74 a share versus the consensus of $1.44. Earnings before interest, taxes, depreciation and amortization of $805 million may exceed...
Candel Therapeutics Shares Are Down Today: What's Going On?
Candel Therapeutics Shares Are Down Today: What's Going On?
Mar 27, 2025
Candel Therapeutics, Inc. ( CADL ) shares are are trading lower Thursday after the company released final survival data from its phase 2a clinical trial of CAN-2409. What To Know: The trial involved patients with stage III/IV non-small cell lung cancer (NSCLC) who had inadequate responses to immune checkpoint inhibitor (ICI) treatment. The median overall survival (mOS) was reported at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved